Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Neurobiol Aging. 2014 Oct 7;36(0 1):S167–S177. doi: 10.1016/j.neurobiolaging.2014.05.039

Table 1.

Number of scans at 6 and 12 months (equal for accelerated and nonaccelerated) broken down by vendor sequence (nonaccelerated/accelerated) and by diagnosis. AD denotes Alzheimer’s disease, EMCI and LMCI denote early and late mild cognitive impairment, and CN denotes healthy controls.

6 Months Diagnosis
Scanner Vendor
(accel/nonaccel sequence)
AD EMCI LMCI CN Total
GE (IR_FSPGR/ASSET) 7 15 12 27 61
Philips (MPRAGE/SENSE) 6 15 23 29 73
Siemens (MPRAGE/GRAPPA) 16 64 57 74 211
Total 29 94 92 130 345
12 Months
Scanner Vendor
(accel/nonaccel sequence)
AD EMCI LMCI CN Total
GE (IR_FSPGR/ASSET) 2 6 4 8 20
Philips (MPRAGE/SENSE) 3 8 11 15 37
Siemens (MPRAGE/GRAPPA) 8 33 23 35 99
Total 13 47 38 58 156